Go to SC301 Plastic Surgery AI Consultation Request
Sera AI Consultation
Sera AI Consultation
Go to SC301 Plastic Surgery AI Consultation Request
Skip to main content
301 blog

SC301 Clinic, Introduced to Korea for Stem Cell Plastic Surgery, Exports Stem Cell Medical Technology to the 13 Billion-Billion Chinese Market

By 2019-04-16No Comments

Signed an MOU with the China Asia-Pacific Beauty Expo Organizing Committee on the 13th for the dissemination of stem cell anti-aging medical treatments.

SC301 Clinic (Chief Director Shin Dong-jin), which pioneered the 'stem cell cosmetic surgery' technique in Korea for the first time in 2007, plans to export advanced Korean stem cell medical technology to the 13 billion-strong Chinese market.


SC301 Clinic announced on the 16th that it signed a "Korea-China Mutual Business Agreement (MOU) for the Development and Dissemination of Advanced Anti-Aging Medical Technologies, Including Stem Cells" with the Asia-Pacific Beauty Expo Organizing Committee (Chairman Chen Zhanhua, hereinafter the Asia-Pacific Beauty Expo Committee), which represents the Chinese beauty industry, at the "SC301 Clinic & China Zhejiang Province Beauty Industry Delegation Dinner for the Development and Dissemination of Advanced Anti-Aging Medical Technologies, Including Stem Cells" event held at the Prima Hotel in Gangnam-gu, Seoul on the 13th.

The Asia-Pacific Beauty Expo Committee is known for hosting the 'Asia-Pacific Beauty Expo,' the second largest beauty and anti-aging trade fair in China after the Shanghai Beauty Expo, and for mediating active exchanges in the beauty and anti-aging industries between Korea and China. 

Thousands of industry professionals from the beauty and anti-aging sectors in Korea and China participate annually in the expo, which is held several times a year alternating between Korea and China. The size of the Chinese beauty and anti-aging market, which is directly linked to them, is also estimated to be over 1000 million people. Through the business agreement signed on this day, SC301 Clinic agreed to cooperate closely with the Asia-Pacific Beauty Expo Committee to advance and disseminate advanced anti-aging medical technologies, such as stem cells.

In particular, both sides agreed to regard each other as the preferred negotiating partner when implementing projects related to anti-aging technologies, such as stem cells, in Korea and China. An official from SC301 Clinic emphasized, "Through this, it has become possible to export advanced anti-aging medical technologies, including stem cells, to China while gaining an advantage over other hospitals."

Both parties also agreed to plan and commission joint projects regarding advanced anti-aging medical technologies, such as stem cells, and to maintain a strategic cooperative relationship by introducing their respective projects, which are currently commercialized, to each other's countries. Through this, SC301 Clinic expects to receive significant assistance in opening up sales channels when exporting its stem cell medical technology to China.

In this regard, Chief Director Shin Dong-jin stated, “Since first introducing stem cell cosmetic surgery technology in Korea, SC301 Clinic has focused exclusively on developing stem cell medical technology for 13 years. This agreement signifies that stakeholders in China’s beauty and anti-aging industries have recognized the value of our domestic brand established through this process. Taking this as an opportunity, SC301 Clinic will do its utmost to successfully export Korea’s advanced stem cell medical technology to the 13 billion-strong Chinese market.”

Chief Director Shin Dong-jin is known as the "founder" who created stem cell plastic surgery techniques in the Korean plastic surgery market, including the first commercialization of stem cell breast augmentation in Korea in 2007. SC301 Clinic is recognized for establishing an unrivaled position in the field, having created various stem cell medical technologies over the past 13 years, focusing on stem cell breast augmentation, as well as stem cell anti-aging and pain treatment, stem cell facial surgery, stem cell female rejuvenation, and stem cell erectile dysfunction treatment.

In addition, it is reported that about 50 business leaders representing China's beauty and anti-aging industries attended the dinner held on the 13th and expressed enthusiastic interest in stem cell cosmetic medical techniques.

source : Geumgang Ilbo (http://www.ggilbo.com)